Benefits of Optiflow® Device for Preoxygenation Before Intubation in Acute Hypoxemic Respiratory Failure : The PREOXYFLOW Study

NACompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

August 31, 2013

Conditions
Acute Hypoxemic Respiratory Failure
Interventions
DEVICE

PREOXYFLOW

"Patients randomized in PREOXYFLOW group will received a four minutes preoxygenation period with Nasal High Flow Therapy (HFT) Optiflow ® (60 l/mn FIO2 = 1) before orotracheal intubation under laryngoscopy after crash induction"

PROCEDURE

STANDARD FACE MASK

"Patients randomized in STANDARD FACE MASK group will received a four minutes preoxygenation period with a standard face mask (15 l/mn) before orotracheal intubation under laryngoscopy after crash induction. Each hospital involved in this study will use the standard face mask as per its usual practice (no specific trademark requested by this protocol)"

Trial Locations (6)

29609

Brest Universitary Hospital, Brest

34295

Montpellier University hospital, Montpellier

44093

Nantes Universitary Hospital, medical intensive care unit, Nantes

Nantes Universitary Hospital, surgical intensive care unit, Nantes

49933

Angers Universitary Hospital, Angers

85925

La Roche/Yon Hospital, La Roche/Yon

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT01747109 - Benefits of Optiflow® Device for Preoxygenation Before Intubation in Acute Hypoxemic Respiratory Failure : The PREOXYFLOW Study | Biotech Hunter | Biotech Hunter